title: [New aspects on the pathogenesis of psoriatic arthritis].
abstract: Psoriasis and psoriatic arthritis (PsA) are immune-mediated inflammatory diseases with a high burden of disability and increased mortality. The pathogenesis of the disease comprises a dysregulated interaction between stromal and immune cells and a dysfunctional cytokine network supporting chronic inflammation of the skin, entheses and joints. In addition to recent advances in the understanding of TNF blockade, more targets have been discovered delivering insights into the pathogenesis of PsA. This article gives a translational approach by utilizing current clinical development programs providing an insight into the IL-12/IL-23 and the IL-17 axes and also focuses on tissue damage and new small molecules.
authors.affiliation: Medizinische Klinik 3, Rheumatologie und Immunologie, Universitätsklinikum Erlangen, Ulmenweg 18, 91054, Erlangen, Deutschland, axel.hueber@uk-erlangen.de.
authors.forename: A J
authors.initials: AJ
authors.lastname: Hueber
authors.forename: B
authors.initials: B
authors.lastname: Manger
mesh_terms: D015535:Arthritis, Psoriatic / Q000276:immunology* / Q000473:pathology*; D016207:Cytokines / Q000276:immunology*; D006801:Humans; D007596:Joints / Q000276:immunology* / Q000473:pathology*; D018448:Models, Immunological; D012867:Skin / Q000276:immunology* / Q000473:pathology*
chemical_list: D016207:Cytokines
references.citation: Arthritis Res Ther. 2013 Mar 01;15(2):R38
references.pmid: 23452551
references.citation: J Immunol. 2010 Apr 1;184(7):3336-40
references.pmid: 20200272
references.citation: Biol Proced Online. 2012 Dec 19;14(1):10
references.pmid: 23253472
references.citation: J Rheumatol. 2012 Dec;39(12):2235-7
references.pmid: 23204311
references.citation: J Clin Invest. 2003 Mar;111(6):821-31
references.pmid: 12639988
references.citation: J Clin Invest. 2005 Jun;115(6):1571-9
references.pmid: 15902307
references.citation: Biochem Pharmacol. 2012 Jun 15;83(12):1583-90
references.pmid: 22257911
references.citation: Ann Rheum Dis. 2013 Sep 1;72(9):1569-74
references.pmid: 23268368
references.citation: Rheumatology (Oxford). 2013 May;52(5):769-79
references.pmid: 23362223
references.citation: Eur J Immunol. 2011 Aug;41(8):2229-37
references.pmid: 21674479
references.citation: Curr Opin Rheumatol. 2009 Jul;21(4):340-7
references.pmid: 19424069
references.citation: Ann Rheum Dis. 2014 Feb;73(2):349-56
references.pmid: 23361084
references.citation: J Rheumatol Suppl. 2012 Jul;89:97-9
references.pmid: 22751605
references.citation: Ann Rheum Dis. 2008 May;67(5):672-6
references.pmid: 17823200
references.citation: Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4448-53
references.pmid: 20160089
references.citation: Bull NYU Hosp Jt Dis. 2012;70(3):204-7
references.pmid: 23259630
references.citation: Arthritis Rheum. 2010 Oct;62(10):2876-85
references.pmid: 20583102
references.citation: Arthritis Res Ther. 2012 Apr 27;14(2):R93
references.pmid: 22541888
references.citation: Lancet. 2009 Feb 21;373(9664):633-40
references.pmid: 19217154
references.citation: Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii116-23
references.pmid: 23253932